Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (151 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 30 Apr 2026 – 20 Aug 2026, limited by Kotak Multi Asset Active FOF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak Multi Asset Active FOF | Nifty 500 |
|---|---|---|
| 30 Apr 2026 | ₹100.00 | ₹100.00 |
| 09 May 2026 | ₹100.13 | ₹101.90 |
| 19 May 2026 | ₹100.99 | ₹99.29 |
| 28 May 2026 | ₹101.59 | ₹101.25 |
| 06 Jun 2026 | ₹100.40 | ₹99.04 |
| 16 Jun 2026 | ₹101.25 | ₹101.38 |
| 25 Jun 2026 | ₹100.10 | ₹101.90 |
| 04 Jul 2026 | ₹101.91 | ₹102.72 |
| 14 Jul 2026 | ₹100.94 | ₹102.27 |
| 23 Jul 2026 | ₹100.67 | ₹101.32 |
| 01 Aug 2026 | ₹101.45 | ₹103.43 |
| 11 Aug 2026 | ₹103.62 | ₹104.40 |
| 20 Aug 2026 | ₹103.92 | ₹103.66 |
| Metric | Kotak Mahindra · Direct NAV ₹10.40 Very High risk Unrated | Category median FoF Domestic · 151 funds |
|---|---|---|
| — | +8.79% | |
| — | +14.76% | |
| — | +11.89% | |
| — | +12.34% | |
| +3.92% | +11.30% | |
| +17.36% | — | |
| — | +13.06% | |
| — | +10.96% | |
| — | +10.76% | |
| Risk | ||
| 9.31% | 15.95% | |
| — | 0.81 | |
| — | 1.14 | |
| -3.70% | -19.45% | |
| Nifty 500 | — | |
| — | +1.81% | |
| — | 0.94 | |
| — | 98.0% | |
| — | 93.1% | |
| 0.35% | 0.17% | |
| ₹51.39Cr | ₹228.08Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹1.00K | — | |
| — | 11% | |
| Abhishek Bisen | — | |
| 30 Apr 2026 | — | |
| — | — | |
| — | — | |
| 5.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.